Furthermore, the analysis of signaling pathways revealed that the LYZ gene is linked to several significant signaling pathways in glioblastoma, such as FceRI-mediated NF-kB activation and immunoregulatory interactions between lymphoid and non-lymphoid cells (p < 0.001) (Figure 3C–F). This evidence concerns the gene LYZ and glioblastoma.